HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 120 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,765,000 | +74.2% | 98,120 | +71.8% | 0.18% | +206.9% |
| Q4 2019 | $1,013,000 | +107.2% | 57,125 | +81.3% | 0.06% | +152.2% |
| Q3 2019 | $489,000 | -9.6% | 31,515 | 0.0% | 0.02% | -4.2% |
| Q2 2019 | $541,000 | +6.7% | 31,515 | 0.0% | 0.02% | +20.0% |
| Q1 2019 | $507,000 | -56.1% | 31,515 | -60.1% | 0.02% | -57.4% |
| Q4 2018 | $1,156,000 | +0.7% | 78,990 | +25.0% | 0.05% | +38.2% |
| Q3 2018 | $1,148,000 | -6.9% | 63,200 | -13.5% | 0.03% | -10.5% |
| Q2 2018 | $1,233,000 | -73.2% | 73,105 | -68.9% | 0.04% | -74.1% |
| Q1 2018 | $4,609,000 | -0.4% | 235,260 | +3.0% | 0.15% | +4.3% |
| Q4 2017 | $4,628,000 | +30.9% | 228,440 | +12.2% | 0.14% | +25.9% |
| Q3 2017 | $3,536,000 | -12.6% | 203,595 | -35.5% | 0.11% | +2.8% |
| Q2 2017 | $4,044,000 | +83.5% | 315,440 | +85.5% | 0.11% | +73.0% |
| Q1 2017 | $2,204,000 | +33.3% | 170,030 | +1.7% | 0.06% | +43.2% |
| Q4 2016 | $1,653,000 | +62.7% | 167,260 | +98.9% | 0.04% | +57.1% |
| Q3 2016 | $1,016,000 | +535.0% | 84,090 | +566.1% | 0.03% | +600.0% |
| Q1 2014 | $160,000 | -18.8% | 12,625 | -4.0% | 0.00% | -33.3% |
| Q4 2013 | $197,000 | – | 13,150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |